United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news Kirloskar Oil Engines rallies on robust Q4 margins, Rs 5,073cr full-year sales Kirloskar Oil Engines surged nearly 17% after record Q4 sales and a strong FY2025 earnings report. Find out how KOEL is powering India’s hybrid energy future. byPallavi MadhirajuMay 16, 2025